Bioceres Crop Solutions Corp.
BIOX Basic Materials Agricultural Inputs
Bioceres Crop Solutions Corp.’s revenue for fiscal 2026 (year ended June 2026) was $238.2 million, down 28.6% from fiscal 2025. In the quarter to March 2026, revenue fell 34.7%, EPS fell 700.0%, free cash flow grew 344.3% and total debt fell 29.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow BIOX
An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
238.20 | 333.57 | 462.40 | 415.71 | 334.80 | 209.53 | 173.09 | 160.33 | 133.54 | — |
Revenue Growth |
(28.59%) | (27.86%) | 11.23% | 24.16% | 59.79% | 21.05% | 7.96% | 20.06% | (16.71%) | — |
Cost of Revenue |
155.40 | 203.42 | 278.22 | 235.46 | 208.36 | 118.64 | 93.58 | 86.96 | 77.09 | — |
Gross Profit |
82.80 | 130.14 | 184.18 | 180.25 | 126.44 | 90.88 | 79.52 | 73.36 | 56.45 | — |
R&D Expenses |
— | 14.91 | 17.18 | 15.35 | 6.95 | 5.62 | 4.20 | 3.69 | 3.95 | 0.00 |
SG&A Expenses |
— | 123.11 | 123.69 | 113.00 | 77.48 | 47.60 | 38.35 | 39.24 | 35.26 | — |
Operating Income |
(0.30) | (2.24) | 45.85 | 54.18 | 39.87 | 38.38 | 39.15 | 32.09 | 15.71 | — |
Non-operating Income/Expense |
(50.90) | (55.34) | (34.79) | (35.08) | (25.81) | (27.85) | (32.70) | (41.46) | (40.95) | — |
Non-operating Interest Expenses |
50.90 | 55.34 | 34.79 | 35.08 | 25.81 | 27.85 | 32.70 | 41.46 | 40.95 | 0.00 |
Investment Gain/Loss (Other) |
— | — | — | — | — | — | — | — | — | 0.00 |
Income (Other) |
— | — | — | — | — | — | — | — | — | 0.00 |
| (51.00) | (57.57) | 11.07 | 19.11 | 14.06 | 10.53 | 6.44 | (9.37) | (25.24) | 0.00 | |
Income Tax Provision |
3.40 | 1.27 | 3.78 | (1.07) | 17.97 | 14.35 | 2.21 | 6.99 | (10.93) | 0.00 |
Income after Tax |
(54.40) | (58.85) | 7.29 | 20.17 | (3.91) | (3.82) | 4.24 | (16.36) | (14.31) | — |
Minority Interest |
— | — | — | — | — | — | — | — | — | 0.00 |
Dividends (Preferred) |
— | — | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 | — |
Non-Controlling Interest |
— | (3.43) | 3.01 | 1.39 | 3.29 | 3.05 | 0.88 | 2.01 | (3.27) | — |
Net Income Common |
(54.40) | (55.42) | 4.28 | 18.78 | (7.20) | (6.87) | 3.36 | (18.37) | (11.04) | — |
EPS (Basic) |
(0.86) | (0.82) | 0.05 | 0.27 | (0.17) | (0.18) | 0.09 | (0.73) | (0.01) | — |
EPS (Diluted) |
(0.86) | (0.82) | 0.05 | 0.26 | (0.17) | (0.18) | 0.09 | (0.54) | (0.51) | — |
Shares (Basic, Weighted) |
63.60 | 63.23 | 62.84 | 62.15 | 42.30 | 39.22 | 36.12 | 30.48 | 28.10 | — |
Shares (Diluted, Weighted) |
63.60 | 63.23 | 63.49 | 63.19 | 42.30 | 39.22 | 36.42 | 30.48 | 28.10 | — |
Gross Margin |
34.76% | 39.02% | 39.83% | 43.36% | 37.76% | 43.38% | 45.94% | 45.76% | 42.27% | — |
EBIT Margin |
(0.13%) | (0.67%) | 9.92% | 13.03% | 11.91% | 18.32% | 22.62% | 20.01% | 11.76% | — |
EBT margin |
(21.41%) | (17.26%) | 2.39% | 4.60% | 4.20% | 5.03% | 3.72% | (5.85%) | (18.90%) | 0.00% |
Net Profit Margin |
(22.84%) | (16.61%) | 0.92% | 4.52% | (2.15%) | (3.28%) | 1.94% | (11.46%) | (8.27%) | — |
Free Cash Flow Margin |
0.00% | 13.28% | 6.73% | (2.19%) | (5.77%) | (7.59%) | 3.54% | 16.99% | 11.30% | 0.00% |
EBITDA |
(0.30) | 19.95 | 67.15 | 73.57 | 49.06 | 44.65 | 43.88 | 36.91 | 20.08 | — |
EBIT |
(0.30) | (2.24) | 45.85 | 54.18 | 39.87 | 38.38 | 39.15 | 32.09 | 15.71 | — |
Income from Continuous Operations |
(54.40) | (58.85) | 7.29 | 20.17 | (3.91) | (3.82) | 4.24 | (16.36) | (14.31) | — |
Income from Discontinued Operations |
— | — | — | — | — | — | — | — | — | 0.00 |
Consolidated Net Income/Loss |
(54.40) | (58.85) | 7.29 | 20.17 | (3.91) | (3.82) | 4.24 | (16.36) | (14.31) | — |
EPS (Basic, from Continuous Ops) |
(0.86) | (0.93) | 0.12 | 0.32 | (0.09) | (0.10) | 0.12 | (0.54) | (0.51) | — |
EPS (Basic, Consolidated) |
(0.86) | (0.93) | 0.12 | 0.32 | (0.09) | (0.10) | 0.12 | (0.54) | (0.51) | — |
EPS (Diluted, from Cont. Ops) |
(0.86) | (0.93) | 0.11 | 0.32 | (0.09) | (0.10) | 0.12 | (0.54) | (0.51) | — |
Shares (Diluted, Average) |
63.60 | 63.20 | 63.80 | 63.19 | 42.30 | 39.22 | 36.42 | — | — | — |
EPS (Diluted, Consolidated) |
(0.86) | (0.93) | 0.11 | 0.32 | (0.09) | (0.10) | 0.12 | (0.54) | (0.51) | — |
EBITDA Margin |
(0.13%) | 5.98% | 14.52% | 17.70% | 14.65% | 21.31% | 25.35% | 23.02% | 15.04% | — |
Operating Cash Flow Margin |
0.00% | 14.96% | 9.02% | 0.62% | (5.23%) | (2.96%) | 5.38% | 18.52% | 13.77% | 0.00% |